The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation

Peer Review reports

Original Submission
24 Sep 2015	Submitted	Original manuscript
15 Feb 2016	Author responded	Author comments - Carmel Collins
Resubmission - Version 2
15 Feb 2016	Submitted	Manuscript version 2
Publishing
27 May 2016	Editorially accepted
1 Jun 2016	Article published	10.1186/s12887-016-0611-0

Back to article page